Evidence map›Paper›PMID 28197857›Full record

ArticleInflammation2017

Diallyl Disulfide Suppresses the Inflammation and Apoptosis Resistance Induced by DCA Through ROS and the NF-κB Signaling Pathway in Human Barrett's Epithelial Cells.

Cheng Feng, Yumei Luo, Yuanyuan Nian, Dong Liu, Xiaoran Yin, Jing Wu, Jia Di, Rong Zhang, Jun Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
10.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Mechanisms and Application of Gas-Based Anticancer Therapies.Pharmaceuticals (Basel, Switzerland) · 2023
    Review
  5. Article
  6. Article
  7. Piperine Derived fromFoods (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Biological Functions of Diallyl Disulfide, a Garlic-Derived Natural Organic Sulfur Compound.Evidence-based complementary and alternative medicine : eCAM · 2021
    Review
  17. Role of hydrogen sulfide donors in cancer development and progression.International journal of biological sciences · 2021
    Review
  18. Review
  19. Article
  20. Diallyl disulfide alleviates inflammatory osteolysis by suppressing osteoclastogenesisFASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Cheng FengDivision of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710003, China.
Yumei LuoDivision of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710003, China.
Yuanyuan NianDivision of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710003, China.
Dong LiuDivision of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710003, China.
Xiaoran YinDivision of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710003, China.
Jing WuDivision of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710003, China.
Jia DiDivision of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710003, China.
Rong ZhangDivision of Gastroenterology, Shaanxi Provincial People's Hospital, Xi'an, 710068, China.
Jun ZhangDivision of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710003, China. junzhang_xjtu@163.com.
Second Affiliated Hospital of Xi'an Jiaotong University · CNShaanxi Provincial People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Barrett's esophagus (BE) is generally accepted as the only precursor to esophageal adenocarcinoma (EAC). Deoxycholic acid (DCA)-induced inflammation and apoptotic resistance play an important role in the carcinogenesis and progression from BE to EAC. Diallyl disulfide (DADS) is a garlic-derived natural organosulfur compound. This study investigated whether DADS has chemopreventive effects against BE and the potentially related signaling pathway. BAR-T cells were treated with DCA in the presence or absence of DADS. An MTT assay was used to detect the viability of the cells. The apoptosis rate of the cells was measured by light microscopy and flow cytometry. ROS levels were determined by fluorescence microscopy and flow cytometry. Real-time PCR and ELISA were used to detect mRNA and protein levels, respectively. The levels of target proteins were also determined by western blot analysis. DADS did not inhibit cell viability in a certain concentration range. DADS, similar to the NF-κB inhibitor PDTC, inhibited the DCA-induced ROS production, inflammatory factors, IκBα phosphorylation, and expression of p50 in the nucleus in a dose-dependent manner. DADS also increased the cell apoptosis rate through down-regulating the level of Bcl-2. DADS has low cytotoxicity in BAR-T cells. It has an anti-inflammatory effect in BAR-T cells through inhibiting ROS and the NF-κB signaling pathway. Further, it abolishes the apoptotic resistance induced by DCA in an NF-κB/Bcl-2 dependent manner. DADS may be a good candidate for BE and EAC chemical prevention and therapy.

Indexed as

Allyl CompoundsAntihypertensive AgentsApoptosisDeoxycholic AcidDisulfidesEpithelial CellsHumansInflammationNF-kappa BProto-Oncogene Proteins c-bcl-2Reactive Oxygen SpeciesSignal TransductionAllyl CompoundsAntihypertensive AgentsDeoxycholic Aciddiallyl disulfideDisulfidesNF-kappa BProto-Oncogene Proteins c-bcl-2Reactive Oxygen Speciesapoptotic resistanceBarrett’s esophaguschemical preventiondeoxycholic aciddiallyl disulfideinflammation

Identifiers

PMID28197857
OpenAlexW2588397791

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.